Industry
Bayer Licenses Immunoassays to Signet Labs
A licensing agreement has been announced by Bayer HealthCare Diagnostics Division, whereby Signet Laboratories, Inc., will conduct research with immunoassays discovered by Bayer scientists that detect two markers of inflammation, uristatin (Uri) and bikunin (Bik), which are found in blood and urine More...10 Mar 2006
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Capillary Blood Collection Tube
IMPROMINI M3
Human Estradiol Assay
Human Estradiol CLIA Kit
In Other News
Beta Device for Detecting Cervical Cancer
Olympus Moves Into Immunoassays
New Test for Staph Infections
Personalized Test for Cancer Drug
Innogenetics Acquires PCR License
Prenatal Diagnostic Technology Licensed
Alliance for Biomarker Validation Technologies
ExonHit and bioMerieux Extend Alliance
Collaboration to Develop Sepsis Diagnostics
Diagnostic Acquisitions Expand Inverness
Bayer Contracts for New Immunoassays
Bayer and CIS Biotech in Assay Alliance
Olympus Opens New Immunoassay Facility
Alliance to Develop Diagnostic Tests
McCormick Scientific Takes Over Paraplast
Nanogen Awarded Grant for Sepsis System
Mayo and LipoScience in Collaboration
Dynex to Market Binding Site's Workstation
Quest to Acquire LabOne for $934 Million
LipoScience to Market LipoProfile Test
Alliance Focuses on TB Test
Real-Time PCR Technology Licensed
Diagnostic Technology Licensed to Bayer
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.